The
reactivity of a series of Cp*IrIII(L) complexes
that contain a diverse set of ancillary ligands, L, (L = PMe3, N-heterocyclic carbene, NHC = 1,3-dimethylimidazol-2-ylidene, aqua,
4-t-butylpyridine, and 4-(2,4,6-tris-(4-t-butylphenyl)pyridinium)pyridine tetrafluoroborate) has been examined
in catalytic H/D exchange reactions between C6H6 and a series of deuterated solvents (methanol-d
4, acetic acid-d
4, and trifluoroacetic
acid-d
1). These studies demonstrate that
(1) the mechanism of catalytic H/D exchange is significantly influenced
by the nature of the solvent; (2) electron-donating ligands (PMe3, NHC) promote the formation of Ir hydrides in methanol-d
4, and these are critical intermediates in catalytic
H/D exchange processes; and (3) weak/poorly donating ligands (4-t-butylpyridine, 4-(2,4,6-tris-(4-t-butylphenyl)pyridinium)pyridine
tetrafluoroborate and aqua) can support efficient H/D exchange catalysis
in acetic acid-d
4.
Methanol formation from [Cp*Ir(III)(NHC)Me(CD2Cl2)](+) occurs quantitatively at room temperature with air (O2) as the oxidant and ethanol as a proton source. A rare example of a diiridium bimetallic complex, [(Cp*Ir(NHC)Me)2(μ-O)][(BAr(F)4)2], 3, was isolated and shown to be an intermediate in this reaction. The electronic absorption spectrum of 3 features a broad observation at ∼660 nm, which is primarily responsible for its blue color. In addition, 3 is diamagnetic and can be characterized by NMR spectroscopy. Complex 3 was also characterized by X-ray crystallography and contains an Ir(IV)-O-Ir(IV) core in which two d(5) Ir(IV) centers are bridged by an oxo ligand. DFT and MCSCF calculations reveal several important features of the electronic structure of 3, most notably, that the μ-oxo bridge facilitates communication between the two Ir centers, and σ/π mixing yields a nonlinear arrangement of the μ-oxo core (Ir-O-Ir ∼ 150°) to facilitate oxygen atom transfer. The formation of 3 results from an Ir oxo/oxyl intermediate that may be described by two competing bonding models, which are close in energy and have formal Ir-O bond orders of 2 but differ markedly in their electronic structures. The radical traps TEMPO and 1,4-cyclohexadiene do not inhibit the formation of 3; however, methanol formation from 3 is inhibited by TEMPO. Isotope labeling studies confirmed the origin of the methyl group in the methanol product is the iridium-methyl bond in the [Cp*Ir(NHC)Me(CD2Cl2)][BAr(F)4] starting material. Isolation of the diiridium-containing product [(Cp*Ir(NHC)Cl)2][(BAr(F)4)2], 4, in high yields at the end of the reaction suggests that the Cp* and NHC ligands remain bound to the iridium and are not significantly degraded under reaction conditions.
A series of monomethyl Cp*IrIII complexes were synthesized
and studied for the formation of methanol in water. Methanol yields
of 75(4)% in the presence of O2 were obtained. From isotope
labeling studies, it was determined that O2 is the source
of the oxygen atom in the product. From kinetic studies, oxyfunctionalization
appears to proceed by dissociation of an L-type ligand followed by
O2 binding and insertion.
The supported titanium catalyst s(FI)Ti, generated by adding (FI)TiCl 3 to MAO-treated SiO 2 (FI = (N-(5-methyl-3-(1-adamantyl)salicylidene)-2'-(2"-methoxyphenyl)anilinato)], effects the selective trimerization of the linear α-olefins (LAOs) propene, 1-pentene, 1-hexene, 1-decene, with >95% selectivity for trimers and ~85% selectivity to a single isomer thereof (2,3,5-trialkyl-1-hexene). Mechanistic interpretations are offered for the high regioselectivity as well as for some unusual kinetics behavior, including third-order dependence on LAO concentration and nearly identical initial rates at 0 and 25 °C.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.